346 related articles for article (PubMed ID: 20025845)
1. Selective binding of the fluorescent dye 1-anilinonaphthalene-8-sulfonic acid to peroxisome proliferator-activated receptor gamma allows ligand identification and characterization.
Zorrilla S; Garzón B; Pérez-Sala D
Anal Biochem; 2010 Apr; 399(1):84-92. PubMed ID: 20025845
[TBL] [Abstract][Full Text] [Related]
2. Combined biophysical and cell-based approaches for the assessment of ligand binding to PPARγ.
Zorrilla S; Pérez-Sala D
Methods Mol Biol; 2013; 952():237-52. PubMed ID: 23100238
[TBL] [Abstract][Full Text] [Related]
3. Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands.
Waku T; Shiraki T; Oyama T; Morikawa K
FEBS Lett; 2009 Jan; 583(2):320-4. PubMed ID: 19101554
[TBL] [Abstract][Full Text] [Related]
4. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
[TBL] [Abstract][Full Text] [Related]
5. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.
Xu X; Lu Y; Chen L; Chen J; Luo X; Shen X
Steroids; 2013 Sep; 78(9):813-22. PubMed ID: 23707573
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
Chana RS; Lewington AJ; Brunskill NJ
Kidney Int; 2004 Jun; 65(6):2081-90. PubMed ID: 15149321
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel PPARγ ligand screening system using pinpoint fluorescence-probed protein.
Nagai H; Ebisu S; Abe R; Goto T; Takahashi N; Hosaka T; Kawada T
Biosci Biotechnol Biochem; 2011; 75(2):337-41. PubMed ID: 21307572
[TBL] [Abstract][Full Text] [Related]
9. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
[TBL] [Abstract][Full Text] [Related]
10. A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist.
Chen Q; Chen J; Sun T; Shen J; Shen X; Jiang H
Anal Biochem; 2004 Dec; 335(2):253-9. PubMed ID: 15556564
[TBL] [Abstract][Full Text] [Related]
11. A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells.
Awais M; Sato M; Umezawa Y
Biosens Bioelectron; 2007 May; 22(11):2564-9. PubMed ID: 17095203
[TBL] [Abstract][Full Text] [Related]
12. Spectroscopic analyses of the binding kinetics of 15d-PGJ2 to the PPARgamma ligand-binding domain by multi-wavelength global fitting.
Shiraki T; Kodama TS; Shiki S; Nakagawa T; Jingami H
Biochem J; 2006 Feb; 393(Pt 3):749-55. PubMed ID: 16236024
[TBL] [Abstract][Full Text] [Related]
13. Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition.
Dong YW; Wang XP; Wu K
World J Gastroenterol; 2009 Jan; 15(4):441-8. PubMed ID: 19152448
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Kaplan J; Cook JA; O'Connor M; Zingarelli B
Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
[TBL] [Abstract][Full Text] [Related]
15. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
16. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
Shim J; Kim BH; Kim YI; Kim KY; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
[TBL] [Abstract][Full Text] [Related]
17. High-performance affinity purification for identification of 15-deoxy-Δ 12,14 -PGJ₂ interacting factors using magnetic nanobeads.
Maekawa N; Hiramoto M; Sakamoto S; Azuma M; Ito T; Ikeda M; Naitou M; Acharya HP; Kobayashi Y; Suematsu M; Handa H; Imai T
Biomed Chromatogr; 2011 Apr; 25(4):466-71. PubMed ID: 21374648
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma (PPARγ) has multiple binding points that accommodate ligands in various conformations: Structurally similar PPARγ partial agonists bind to PPARγ LBD in different conformations.
Ohashi M; Gamo K; Oyama T; Miyachi H
Bioorg Med Chem Lett; 2015 Jul; 25(14):2758-62. PubMed ID: 26025876
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice.
Kuboki S; Shin T; Huber N; Eismann T; Galloway E; Schuster R; Blanchard J; Zingarelli B; Lentsch AB
Hepatology; 2008 Jan; 47(1):215-24. PubMed ID: 18085707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
